I presented our work on HbF induction by BMS-986470 at EHA 2026 in Stockholm, Sweden.

Excited to share that I presented our work on HbF induction by BMS-986470, a novel CELMoD agent for sickle cell disease, at the European Hematology Association (EHA) Annual Congress 2026 in Stockholm, Sweden.

Read the full story here.